Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Icu Medical (ICUI) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Icu Medical (ICUI) over the last 17 years, with Q3 2025 value amounting to -$1.9 million.

  • Icu Medical's Net Income towards Common Stockholders rose 9437.59% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.7 million, marking a year-over-year increase of 9220.05%. This contributed to the annual value of -$117.7 million for FY2024, which is 29685.72% down from last year.
  • According to the latest figures from Q3 2025, Icu Medical's Net Income towards Common Stockholders is -$1.9 million, which was up 9437.59% from $32.5 million recorded in Q2 2025.
  • In the past 5 years, Icu Medical's Net Income towards Common Stockholders ranged from a high of $32.5 million in Q2 2025 and a low of -$39.5 million during Q1 2024
  • Its 5-year average for Net Income towards Common Stockholders is -$5.4 million, with a median of -$9.9 million in 2023.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first crashed by 55569.22% in 2024, then soared by 25183.13% in 2025.
  • Quarter analysis of 5 years shows Icu Medical's Net Income towards Common Stockholders stood at $19.9 million in 2021, then plummeted by 177.97% to -$15.5 million in 2022, then dropped by 10.37% to -$17.1 million in 2023, then plummeted by 38.96% to -$23.8 million in 2024, then surged by 92.22% to -$1.9 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$1.9 million for Q3 2025, versus $32.5 million for Q2 2025 and -$15.5 million for Q1 2025.